the main

news

Semaphorin 7a may be useful for the prediction of lung adenocarcinoma.

January 10, 2019 16:38

A new protein to fight cancer

Researchers have developed a powerful anti-cancer drug and an effective means of treatment of autoimmune diseases.

Cancer cells need special modification for expression of sets of genes for cell proliferation and tumor progression.

Conducted randomized trials in which pembrolizumab used as therapy first and second lines.

The researchers assessed the risk of opioid dependence after undergoing treatment for cancer.

Development of myeloid leukemia is a very rare side effect of cancer treatment.

African American women faced more often with delayed diagnosis and inadequate medical care.

APPLICATION FOR TREATMENT

By submitting this form you agree to the privacy policy

Comments

No comments yet

new comment

necessarily

definitely (will not be published)